Abstract
A Retrospective Head-to-Head Comparison between Pacritinib and Ruxolitinib in Patients with Myelofibrosis and Moderate to Severe Thrombocytopenia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have